Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-18 1:45 pm Purchase | 13D | Xenetic Biosciences Inc. XBIO | CLS Therapeutics LLC | 215,964 14.000% | 17,076 (+8.59%) | View |
| 2023-09-18 12:21 pm Purchase | 13D | Xenetic Biosciences Inc. XBIO | CLS Therapeutics LLC | 198,888 13.000% | 51,388 (+34.84%) | View |
| 2023-06-15 5:20 pm Sale | 13D | Xenetic Biosciences Inc. XBIO | CLS Therapeutics LLC | 147,500 9.700% | -1,327,500 (-90.00%) | View |
| 2022-10-21 4:19 pm Purchase | 13G | Xenetic Biosciences Inc. XBIO | CLS Therapeutics LLC | 1,475,000 9.700% | 1,475,000 (New Position) | View |